Addition of the CDK 4/6 inhibitor improved progression-free survival by 15.2 months for patients with HR+/HER2+ advanced ...

A machine learning tool incorporating both clinical and genomic data helps predict response to CDK4/6 inhibitor therapy in ...

The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)–positive locally advanced or ...

For many people with early breast cancer (eBC), remission doesn’t mean everything goes back to normal. There are scars from ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

Nurses play an important role in the administration of biosimilars and the education of patients receiving them.

A promising breakthrough in the fight against cancer emerges from Russia. The cancer vaccine developed by the Gamaleya Center shows surprising results in preclinical trials, dissolving tumors and ...

Reid Bissonnette, Ph.D, Executive Consultant for Translational Research and Development at Xenetic, discusses extension of ...

Cancer cells exhibit a distinct metabolism compared to normal cells, characterized by enhanced glycolysis and glutaminolysis ...

The University of Hawaii Cancer Center and the John A. Burns School of Medicine today are launching a historic partnership ...

The NCCN has endorsed the Prolaris prostate cancer prognostic test, reinforcing its position as a critical tool in prostate ...

Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...